Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin.

Organisations Organisation Bayer Pharma AG
  Group Bayer (Group)
  Organisation 2 Kandy Therapeutics Ltd.
  Group Bayer (Group)
Products Product NT-814 (NeRRe Therapeutics / KaNDy Therapeutics)
  Product 2 women’s health
Index term Index term Kandy Therapeutics–Bayer: investment, 202008–202009 acquisition $425m upfront + $450m developm milestones + triple digit $m sales milestones
Persons Person Oelrich, Stefan (Bayer 201811– Head of Pharma division before Sanofi Head of Diabetes + Cardiovascular)
  Person 2 Kerr, Mary (Nerre Therapeutics 201510– CEO before GSK + Advent Life Sciences)
     


   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top